h-trak renewed again on the UK G-Cloud 11 Framework
Aylesbury, 2nd July 2019: The UK team of Prospitalia h-trak are delighted that h-trak has been awarded once again onto the Crown Commercial Services (CCS) G-Cloud 11 Framework, under Lot 2: Cloud software.
Developed for use primarily by NHS acute trusts, the h-trak solution captures and decodes GS1 barcodes to accurately identify products used in surgical and interventional procedures. When combined with other data captured in the system such as timing points, staff attendance and procedure types, h-trak provides a rich source of procedure information, including procedure costs – and can integrate with local procurement and PLICs systems. Finance, Clinical and Procurement managers use the data to review performance; address clinical variance and make informed decisions to enable cost and efficiency savings.
h-trak is proving invaluable with several leading NHS hospital trusts using the system, namely Ashford and St Peter’s Hospitals NHS Foundation Trust, Gloucestershire Hospitals NHS Foundation Trust, London North West University Healthcare NHS Trust, South West London Elective Orthopaedic Centre (SWLEOC), University Hospitals of Derby and Burton NHS Foundation Trust and University Hospitals of Leicester NHS Trust.
As well as delivering vital patient safety improvements through its track and trace functionality, h-trak is helping trusts to achieve considerable cost efficiencies in reducing levels of inventory; automating time consuming manual tasks; releasing time for greater patient care and making clinical process improvements.
Asked about the benefit of the framework for its NHS customers, Nadine Carey-Whitehead, UK General Manager, Prospitalia h-trak states ‘Clinical Directors, Heads of Procurement and Directors of Finance in acute trusts can now simply, through the Digital Marketplace, use the CCS framework call-off agreement for setting up their contracts with us, rather than undertaking an often lengthy and costly tender process. We believe that this additional route to market will enable trusts to progress more efficiently with their GS1 transformations; patient safety aspirations and manage their non-pay and procedure costs.’